Subject
Editions published in Neurodegenerative Diseases 798
-
BACE1 and presenilin: two unusual aspartyl proteases involved in Alzheimer's disease
-
Cerebrospinal fluid profile of amyloid beta peptides in patients with Alzheimer's disease determined by protein biochip technology
-
Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings
-
The long processes of short interfering RNAs--RNA interference and its implications in neuronal cells.
-
Neuronal apoptosis in neurodegenerative diseases: from basic research to clinical application
-
Mitochondria in amyotrophic lateral sclerosis: a trigger and a target
-
The role of ubiquitin-protein ligases in neurodegenerative disease
-
Neurotrophic factors and amyotrophic lateral sclerosis
-
The biochemical and genetic odyssey to the function of a nicastrin-like protein
-
Plasmin deficiency in Alzheimer's disease brains: causal or casual?
-
Problems and solutions in the genetic analysis of late-onset Alzheimer's disease
-
Clinical and molecular aspects of frontotemporal dementia
-
The TAT protein transduction domain enhances the neuroprotective effect of glial-cell-line-derived neurotrophic factor after optic nerve transection
-
Hypocapnia induces caspase-3 activation and increases Abeta production
-
Influence of different promoters on the expression pattern of mutated human alpha-synuclein in transgenic mice.
-
A non-viral vector for targeting gene therapy to motoneurons in the CNS.
-
Lithium decreases secretion of Abeta1-42 and C-truncated species Abeta1-37/38/39/40 in chicken telencephalic cultures but specifically increases intracellular Abeta1-38.
-
Voxel-based morphometry in tau-positive and tau-negative frontotemporal lobar degenerations
-
Assessment of the bioactivity of antibodies against beta-amyloid peptide in vitro and in vivo
-
Changes in dopamine D2 receptors and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake in the brain of 6-hydroxydopamine-lesioned rats
-
Unchanged scrapie pathology in brain tissue of tyrosine kinase Fyn-deficient mice.
-
Beta-amyloid treatment sensitizes mice to amphetamine-induced locomotion but reduces response to caffeine
-
Active immunization of mice with an Abeta-Hsp70 vaccine.
-
A model system to study intracellular trafficking and processing of the Alzheimer's amyloid precursor protein
-
List of drugs in development for neurodegenerative diseases. Update June 2004.
-
Presenilin 1 and cadherins: stabilization of cell-cell adhesion and proteolysis-dependent regulation of transcription.
-
List of drugs in development for neurodegenerative diseases
-
List of drugs in development for neurodegenerative diseases. Update March 2005
-
TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease
-
Mutant SOD1 instability: implications for toxicity in amyotrophic lateral sclerosis
-
Clinical observations with AN-1792 using TAPIR analyses
-
Amyotrophic lateral sclerosis: new developments in diagnostic markers
Subject -